Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

Stopped Study was never initiated under new location/provider group. Contract to continue was never signed between TEVA and Kennedy Headache Center

Conditions

• Chronic Migraine

Interventions

• DRUG: cyclobenzaprine hydrochloride
• DRUG: placebo

Sponsor

Kennedy Medical Group

Collaborators

• [object Object]